HDAC6-IN-42 (compound 2b) is an HDAC6 inhibitor with an IC50 of 0.009 µM, demonstrating significant anti-leukemia activity and synergistic effects with Decitabine, indicating its potential use in the research of Acute Myeloid Leukemia (AML).
Formula:
C24H28FN3O4
Target:
HDAC
* VAT and and shipping costs not included. Errors and price changes excepted
